Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 6 January 2021
EventHumanCOVID-19
Date
- Wednesday, 06 January 2021
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
This extraordinary meeting is organised in the context of the evaluation of the COVID-19 vaccine mRNA-1273 developed by Moderna.
The aim of the meeting is to assess additional information received from the company upon request of the Agency and to conclude the evaluation, if possible.
The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.